Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2008 | 64 | 05 |
Tytuł artykułu

Strategia stosowania szczepionek zalezna od charakteru choroby zakaznej

Warianty tytułu
Vaccination strategy dependent on the character of the infectious disease
Języki publikacji
The role of vaccines in the control of different infectious diseases of animals and in the eradication of their etiological agents in their organisms (carriership) was evaluated. The following diseases were the subject of this review: foot and mouth disease, classical swine fever, highly pathogenic avian influenza, Aujeszky’s disease, infectious bovine rhinotracheitis and diseases caused by facultatively pathogenic microorganisms. After a time period when the stamping out method was recommended, in some cases totally replacing vaccination, the present approach particularly with regards to eradication and gaining or regaining the status of free zones or countries of the disease in question, was presented. Using the vaccination of non infected animals around the zone of disease occurrence, especially with marker vaccines and the application of DIVA strategy, which enables differentiating infected and vaccinated animals, a more effective and less expensive way leading to the eradication of infection and of elimination of the disease being the prerequisite of the status of freedom of disease was proposed. The paper indicates that in relation to diseases caused by facultatively pathogenic microorganisms the role of vaccines is restricted to their control. Since a commonly occurring carriership without an influence on the productivity of animals occurs, in this case the eradication is without importance.
Opis fizyczny
  • Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy
  • 1.Andersson H. A., Lexman J. A., Robertsson N., Lundeheim J., Wierup M.: Agricultural policy and social return to eradication programs: The case of Aujeszky's disease in Sweden. Prev. Vet. Med. 1997, 29, 311-328.
  • 2.Bech-Nielsen S., Bowman G. L., Miller G. Y., Orloski-Snider K. O., Burkholder R. H., Dodaro S. J.: Pseudorabies (Aujeszky's disease) eradication progress and program cost in Ohio, USA. Prev. Vet. Med. 1995, 22, 41-53.
  • 3.Blancou J., Pastoret P. P.: Role of Vaccination. Veterinary Vaccinology. Pastoret P. P., Blancou J., Vannier P., Verschueren C. (eds.) 1997, 597-609.
  • 4.Blome S., Maindl-Bõkmer A., Loeffen W., Thuer B., Moennig V.: Assessment of classical swine fever diagnostics and vaccination performance. Rev. Sci. Tech. Off. Int. Epiz. 2006, 25, 1025-1038.
  • 5.Capua I., Cattoli G., Marangon S. W., Bardotelli L., Ortali G.: Strategies for the control of avian influenza in Italy. Veterinary Record, 2002, 150 (7), 223.
  • 6.Capua I., Terregino C., Cattoli G., Mutinelli F., Rodriguez J. F.: Development of DIVA - Differentiating infected from vaccinated animals - strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathology 2003, 32, 47-55.
  • 7.Diagnostic Techniques and Vaccines for Foot - and Mouth Disease, Classical Swine Fever, Avian Influenza and other important OIE List A Diseases. Report of the Scientific Committee on Animal Health and Animal Welfare, European Commission. Addopled 24-25th April 2003.
  • 8.Haesebrouck F., Pasmans F., Chers K., Maes D., Ducatelle R., Decostere A.: Efficiency of vaccines against bacterial diseases in swine: what can we expect? Veterinary Microbiology 2004, 100, 255-268.
  • 9.Meuwissen M. P., Horst S. H., Huirne R. B., Dijkhuizen A. A.: A model to estimate the financial consequences of classical swine fever outbreaks: principles and outcomes. Preventive Veterinary Medicine. 1999, 42, 249-270.
  • 10.Moormann R. J., Bouma A., Kramps J. A., Terpstra C., De Smit H. J.: Development of the classical swine fever subunit marker vaccine and comparison diagnostic test. Veterinary Microbiology. 2000, 73, 209-219.
  • 11.Müller T., Batza H. J., Schluter H., Conraths F. J., Mettenleiter T. C.: Eradication of Aujeszky's disease in Germany, J. Vet. Med. B. Infect. Dis. Vet. Public Health 2003, 50, 207-213.
  • 12.Niedbalski W., Kęsy A.: Pryszczyca - nosicielstwo wirusa u przeżuwaczy. Medycyna Wet. 2004, 60, 115-118.
  • 13.Niedbalski W., Wijaszka T., Kęsy A.: Szczepionki markerowe - nowe możliwości zapobiegania i zwalczania pryszczycy. Medycyna Wet. 2003, 59, 279-282.
  • 14.Report on Bovine Herpesvirus 1 (BHV1) marker vaccines and the accompaning diagnostic tests. Scientific Committee on Animal Health and Animal Welfare, 25 October 2000.
  • 15.Salt J.: Vaccination against FMD. Veterinary Vaccinology. Pastoret P. P., Blancou J., Vanier P., Verschuren C. (eds.), Amsterdam, Elsevier 1997, 641-649.
  • 16.Todd D.: Circoviruses: immunosuppressive threats to avian species: a review. Avian Pathology 2000, 29, 373-394.
  • 17.Toma B., Benet J. J., Dufour B., Eloit M., Montou M., Sana M.: Glossaire d'Epidemiologie Animale Editions du Point Veterinaire 1991, 227-229.
  • 18.Truszczyński M., Pejsak Z.: Mechanizm chorobotwórczości cirkowirusów ze szczególnym uwzględnieniem poodsadzeniowego, wielonarządowego zespołu wyniszczającego świń i wskazania do jest zwalczania. Medycyna Wet., w druku.
  • 19.van Drunen Littel-van den Hurk S.: Rationale and perspective on the success of vaccination against bovine herpesvirus-1. Veterinary Microbiology 2006, 113, 275-282.
  • 20.van Oirschot J.: Diva vaccines that reduce virus transmission. J. Biotechnol. 1999, 73, 195-205.,
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.